Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

World’s first Parkinson’s patient treated with unique Deep Brain Stimulation device

06.02.2020

In January, the neurosurgical department of the LMU University Hospital in Munich treated the first Parkinson's patient worldwide with a new neurostimulator, which enables better, more personalized care for patients. The new technology can possibly enable stimulation to be adjusted to the treatment requirements of different situations (e.g. walking, speaking, sleeping) and therefore optimize treatment outcome. Even “complex” everyday situations such as talking and walking at the same time should become easier for patients to manage. The neurosurgeons at the LMU University Hospital were also involved in the development of the new technology during clinical studies.

Deep Brain Stimulation (DBS) is delivered through a medical device, similar to a pacemaker, that controls electrodes in the brain and electrically stimulates precisely defined areas. DBS has been used to treat neurological movement disorders for decades. This new generation of THS systems was now first placed in the subthalamic nucleus (STN) of a patient suffering from Parkinson's.


Doctors control the activity of the pacemaker on the tablet

LMU University Hospital Munich

The system does not only deliver impulses to the brain, it also features the so-called BrainSense technology that enables the constant recording of patients’ brain signals. These recordings can then be evaluated by a physician to optimize stimulation delivery. Up until now, recordings of this kind were not possible.

Treatment plans were optimized based on movement tests carried out in the clinic and - often incomplete - patient records. This new technology allows for brain waves to be continuously recorded, which combined with events recorded by the patient himself (including symptoms or side effects of medication), now enable targeted, personalized and data-controlled neurostimulation.

“DBS is proven to significantly improve motor function in people with Parkinson’s disease compared to standard medication alone and has successfully been used for many years in the treatment of neurological movement disorders,” says PD Dr. Jan H. Mehrkens, Head of Functional Neurology at the LMU Clinic for Neurosurgery in Munich.

“Since we were already able to gain experience with the prototype during clinical studies, we have now come full circle in the development of new DBS technologies for Parkinson's patients.” Prof. Dr. Kai Boetzel, LMU clinic for Neurology added: “The new stimulator can measure the activity of the brain’s motor centers and react to it with different stimulation strengths. We will scientifically investigate, whether this ‘feedback stimulation’ is superior to the previous continuous stimulation.”

Parkinson's disease is the second most common disorder of the central nervous system after Alzheimer's disease. Around one percent of the world’s population over the age of 60 is affected. In Germany roughly 400,000 people suffer from it. Parkinson's disease is a slowly progressing condition.

Gradually, the death of dopamine-producing nerve cells negatively affects the motor system. Parkinson's itself cannot be healed, therapy focuses on alleviating the symptoms. Treatment typically starts with medication to help reduce movement symptoms by increasing dopamine in the brain or mimicking its effects. When the disease has progressed, there are surgical options that include DBS.

Percept BrainSense

The neurostimulator with "BrainSense" technology is approved in the EU for the treatment of symptoms in connection with Parkinson's disease, essential tremor, dystonia, epilepsy and obsessive-compulsive disorder. For approval in the United States, it is currently under review by the United States Department of Health (FDA).

Wissenschaftliche Ansprechpartner:

PD Dr. Jan-Hinnerk Mehrkens
LMU Clinic for Neurosurgery
LMU University Hospital Munich
Phone: +49 (0)89 4400 72899
E-mail: jan.mehrkens@med.uni-muenchen.de

Prof. Dr. Kai Boetzel
LMU Clinic for Neurology
LMU University Hospital Munich
Phone: +49 (0)89 4400 73673
E-mail: kai.boetzel@med.uni-muenchen.de

Philipp Kressirer | idw - Informationsdienst Wissenschaft
Further information:
http://www.klinikum.uni-muenchen.de

More articles from Medical Engineering:

nachricht Covid-19, a prominent role for UniTrento in ultrasound diagnosis
24.03.2020 | Università di Trento

nachricht Modern virtual and augmented reality device can help simulate sight loss
11.03.2020 | City University London

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Junior scientists at the University of Rostock invent a funnel for light

Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.

The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.

Im Focus: Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.

Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....

Im Focus: Artificial solid fog material creates pleasant laser light

An international research team led by Kiel University develops an extremely porous material made of "white graphene" for new laser light applications

With a porosity of 99.99 %, it consists practically only of air, making it one of the lightest materials in the world: Aerobornitride is the name of the...

Im Focus: Cross-technology communication in the Internet of Things significantly simplified

Researchers at Graz University of Technology have developed a framework by which wireless devices with different radio technologies will be able to communicate directly with each other.

Whether networked vehicles that warn of traffic jams in real time, household appliances that can be operated remotely, "wearables" that monitor physical...

Im Focus: Peppered with gold

Research team presents novel transmitter for terahertz waves

Terahertz waves are becoming ever more important in science and technology. They enable us to unravel the properties of future materials, test the quality of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“4th Hybrid Materials and Structures 2020” takes place over the internet

26.03.2020 | Event News

Most significant international Learning Analytics conference will take place – fully online

23.03.2020 | Event News

MOC2020: Fraunhofer IOF organises international micro-optics conference in Jena

03.03.2020 | Event News

 
Latest News

3D printer sensors could make breath tests for diabetes possible

27.03.2020 | Power and Electrical Engineering

TU Bergakademie Freiberg researches virus inhibitors from the sea

27.03.2020 | Life Sciences

The Venus flytrap effect: new study shows progress in immune proteins research

27.03.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>